Please log in to view this page
Username
Password
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
